Development of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancer

RAF kinase is crucially involved in cell proliferation and survival in colorectal cancer (CRC). Patients with metastatic CRC (mCRC) harboring BRAF mutations (BRAFms) not only experience a poor prognosis but also benefit less from therapeutics targeting ERK signaling. With advances in RAF inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Jing-hua, Zhou, Hong, Zhu, Sheng-bin, Huang, Jin-lian, Zhao, Xiao-xu, Ding, Hui, Pan, Yun-long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078078/
https://www.ncbi.nlm.nih.gov/pubmed/30122982
http://dx.doi.org/10.2147/CMAR.S170105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078078/
https://www.ncbi.nlm.nih.gov/pubmed/30122982
http://dx.doi.org/10.2147/CMAR.S170105

Ejemplares similares